Affimed N.V. revenue for the last year amounted to 9.13 M USD, the most of which — 8.95 M USD — came from its highest performing source at the moment, Antibodies, the year earlier bringing 43.46 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Affimed N.V. 8.94 M USD, and the year before that — 43.30 M USD.